Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32492407.
- Also identified by DOI 10.1016/j.cell.2020.05.041 and PMC identifier 7250787.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The SARS-CoV-2 pandemic that causes COVID-19 respiratory syndrome has caused global public health and economic crises, necessitating rapid development of vaccines and therapeutic countermeasures. The world-wide response to the COVID-19 pandemic has been unprecedented with government, academic, and private partnerships working together to rapidly develop vaccine and antibody countermeasures. Many of the technologies being used are derived from prior government-academic partnerships for response to other emerging infections.
Medical subject headings
- Coronavirus Infections
- Pandemics
- Pneumonia, Viral
- Viral Vaccines